1,923
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Previous antibiotic exposure and antibiotic resistance of commensal Staphylococcus aureus in Spanish primary care

ORCID Icon, , , , &
Pages 125-130 | Received 26 Aug 2016, Accepted 31 Jan 2018, Published online: 15 Mar 2018

References

  • Goossens H, Ferech M, Vander Stichele SR, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579–587.
  • Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. Br Med J. 2010;340:c2096.
  • van Belkum A, Verkaik NJ, De Vogel CP, et al. Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis. 2009;199:1820–1826.
  • Aryee A, Edgeworth JD. Carriage, clinical microbiology and transmission of Staphylococcus aureus. Curr Top Microbiol Immunol. 2017;409:1–19.
  • Rolo J, Miragaia M, Turlej-Rogacka A, et al. High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One. 2012;7:e34768.
  • Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Suppl 5):S344–S3449.
  • Gushiken CY, Medeiros LB, Correia BP, et al. Nasal carriage of resistant Staphylococcus aureus in a medical student community. An Acad Bras Ciênc. 2016;88:1501–1509.
  • Mat Azis N, Pung HP, Abdul Rachman AR, et al. A persistent antimicrobial resistance pattern and limited methicillin-resistance-associated genotype in a short-term Staphylococcus aureus carriage isolated from a student population. J Infect Public Health. 2017;10:156–164.
  • Davoodabadi F, Mobasherizadeh S, Mostafavizadeh K, et al. Nasal colonization in children with community acquired methicillin-resistant Staphylococcus aureus. Adv Biomed Res. 2016;5:86.
  • Llor C, Boada A, Pons-Vigués M, et al. [Antibiotic susceptibility of Staphylococcus aureus and Streptococcus pneumoniae in healthy carrier individuals in primary care in Barcelona area]. Aten Primaria. 2018;50:44–52.
  • Michiels B, Appelen L, Franck B, et al. Staphylococcus aureus, including meticillin-resistant Staphylococcus aureus, among general practitioners and their patients: a cross-sectional study. PLoS One. 2015;10:e0140045.
  • van Bijnen EM, Paget J, de Lange-de Klerk ES, et al. Antibiotic exposure and other risk factors for antimicrobial resistance in nasal commensal Staphylococcus aureus: an ecological study in 8 European countries. PLoS One. 2015;10:e0135094.
  • van Bijnen EM, Paget WJ, den Heijer CD, et al. Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community. BMC Fam Pract. 2014;15:175.
  • den Heijer CD, van Bijnen EM, Paget WJ, APRES Study Team, et al. Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S. aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis. 2013;13:409–415. [Erratum in: Lancet Infect Dis. 2013;13:1011].
  • Boada A, Almeda J, Grenzner E, et al. Prevalencia de portadores nasales de Staphylococcus aureus y Streptococcus pneumoniae en atención primaria y factores asociados a la colonización. Enferm Infecc Microbiol Clin. 2015;33:451–457.
  • Van Bijnen EM, den Heijer CD, Paget WJ, et al. The appropriateness of prescribing antibiotics in the community in Europe: study design. BMC Infect Dis. 2011;11:293.
  • EUCAST. European Committee on Antimicrobial Susceptibility Testing. European Society of Clinical microbiology and Infectious Diseases. Breakpoint tables for interpretation of MICs and zone diameters Version 7.1, valid from 2017-03-10. [cited 2017 September 7]. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_7.1_Breakpoint_Tables.pdf
  • Coenen S, Gielen B, Blommaert A, et al. Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. J Antimicrob Chemother. 2014;69:529–534.
  • Campos J, Ferech M, Lázaro E, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother. 2007;60:698–701.
  • Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505–520.
  • Gamblin J, Jefferies JM, Harris S, et al. Nasal self-swabbing for estimating the prevalence of Staphylococcus aureus in the community. J Med Microbiol. 2013;62:437–440.
  • Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis. 2008;197:1226–1234.
  • McMurray CL, Hardy KJ, Verlander NQ, et al. Antibiotic surgical prophylaxis increases nasal carriage of antibiotic-resistant staphylococci. J Med Microbiol. 2015;64:1489–1495.
  • Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364:703–705.
  • Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. 1995;31:13–24.
  • Granizo JJ, Aguilar L, Casal J, et al. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolides and β-lactam consumption in Spain (1979–1997). J Antimicrob Chemother. 2000;46:767–773.
  • Malhotra-Kumar S, Lammens C, Coenen S, et al. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet. 2007;369:482–490.
  • Hare KM, Grimwood K, Chang AB, et al. Nasopharyngeal carriage and macrolide resistance in indigenous children with bronchiectasis randomized to long-term azithromycin or placebo. Eur J Clin Microbiol Infect Dis. 2015;34:2275–2285.
  • van Bijnen EM, Paget J, den Heijer CD, et al. Evidence-based primary care treatment guidelines for skin infections in Europe: a comparative analysis. Eur J Gen Pract. 2014;20:294–300.